BANK OF MONTREAL /CAN/ - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 41 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$8,680,000
+1082.6%
310,000
+1348.6%
0.00%
Q4 2021$734,000
+90.6%
21,400
-1.9%
0.00%
Q3 2021$385,000
-86.5%
21,805
-66.1%
0.00%
-100.0%
Q2 2021$2,844,000
+18.3%
64,280
-28.6%
0.00%
-50.0%
Q1 2021$2,404,000
-12.7%
90,073
-32.6%
0.00%0.0%
Q4 2020$2,755,000
+9083.3%
133,574
+9407.0%
0.00%
Q3 2020$30,000
-6.2%
1,405
-22.2%
0.00%
Q2 2020$32,000
+700.0%
1,805
+196.4%
0.00%
Q1 2020$4,000
-78.9%
609
-78.2%
0.00%
Q4 2019$19,000
-24.0%
2,794
+35.0%
0.00%
Q3 2019$25,000
-26.5%
2,070
-26.7%
0.00%
Q2 2019$34,000
-75.5%
2,823
-74.4%
0.00%
Q1 2019$139,000
+3375.0%
11,026
+1675.5%
0.00%
Q4 2018$4,000
-33.3%
621
+0.5%
0.00%
Q3 2018$6,000
+50.0%
618
+1.5%
0.00%
Q2 2018$4,000
-60.0%
609
-45.8%
0.00%
Q1 2018$10,000
-91.9%
1,123
-81.1%
0.00%
Q4 2017$123,000
+1266.7%
5,930
+1086.0%
0.00%
Q3 2017$9,000
+50.0%
500
-4.6%
0.00%
Q2 2017$6,0005240.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$43,400,0003.81%
BVF INC/IL 3,901,759$69,139,0002.70%
COMMODORE CAPITAL LP 498,079$8,826,0002.33%
Altium Capital Management LP 346,000$6,131,0001.61%
Twin Lakes Capital Management, LLC 139,287$2,468,0001.45%
Opaleye Management Inc. 330,222$5,852,0001.09%
EcoR1 Capital, LLC 1,443,800$25,584,0000.89%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 776,689$13,763,0000.76%
JABODON PT CO 90,656$1,606,0000.66%
Artal Group S.A. 1,500,000$26,580,0000.60%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders